INTRODUCTION
Thanks to medical and surgical progress in the management of children with congenital heart disease (CHD), the number of adults with CHD (ACHD) has steadily increased. With more than 85% of patients currently surviving to adulthood, 1 the number with ACHD now far exceeds the number of children.
Even with expert and continuously improving care during childhood, approximately 20% of patients will require surgery during the first 15 years of adulthood, nearly half of them reoperations. 2 However, there is still uncertainty on risk factors and optimal timing for ACHD surgery. A number of surgical reports are available; their retrospective nature, the voluntary and non consecutive participation in patient registries and the inclusion of non-contemporary data come with limitations, reflected in the wide range of published results. [2] [3] [4] [5] [6] [7] [8] [9] With such uncertainty on accurate operative risk, there may be a natural reluctance to recommend surgery, particularly for patients lacking overt symptoms. This delay however, may compromise patients' longer term outlook, which forms the basis of our contemporary study. We examine, herewith, early and midterm to longer-term outcome and its predictors for ACHD cardiac surgery.
METHODS Institution
The ACHD Centre at the Royal Brompton Hospital (RBH), London, UK, was established in 1975, at the National Heart Hospital, and relocated at the RBH in 1989. Since 1999, the decision to proceed with cardiac surgery has always been the product of multidisciplinary discussions and has evolved during the study period with emerging data on late ACHD pathophysiology and on observed benefits from intervention.
Study design
This was an observational, cohort study of prospectively collected data from all consecutive adult patients with CHD (older than 15 years) undergoing cardiac surgery at the RBH between January 2002 and December 2011. The study protocol was registered and approved by the local ethics committee.
As this was an analysis of data collected for routine clinical care (UK National Research Ethics Service guidance), a waiver of the requirement of written informed consent was obtained. Primary endpoint and additional analyses were specified prior to data retrieval and analysis.
Data
Routine prospectively collected data included demographics, anatomic diagnosis, New York Heart Association (NYHA) class, previous history of surgical or other interventions, indication for surgery, details of index surgery, complications and early mortality. 
Congenital heart disease
Congenital Heart Surgery using the Internationnal Paediatric and Congenital Cardiac Code (IPCCC). 10 We have considered IPCCC as the main procedure, the one reaching the highest Aristotle basic score. 11 Files were regularly reviewed before discharge by an independent database manager. Long-term survival status was assessed through the National Health Service computer system, linked to a national database of patient survival held by the UK's Office for National Statistics, which registers all UK deaths. Additional information on long-term outcome (NYHA class, reoperation, other intervention, new-onset arrhythmia) was obtained from medical records. Data on patients from overseas were secured from referral sources and were complete.
In addition, baseline preoperative transthoracic echocardiograms, performed in our designated laboratory (n=942), were reviewed by one experienced investigator blinded to baseline and outcome data adhering to a prespecified protocol; systemic, subpulmonary or uni-ventricular function was assessed semiquantitatively and classified as normal, mildly, moderately or severely impaired. Tricuspid annular plane systolic excursion (TAPSE) and left ventricular ejection fraction (LVEF) were also used for the quantification of right and left ventricular function, respectively.
Definitions
The Bethesda classification was used to group patients into mild, moderate or severe CHD complexity. 12 Non-elective cardiac surgery was defined as any operation performed within 7 days of initial medical admission (urgent), or on the day of non-scheduled admission (emergency). Redo sternotomy was defined as a sternotomy performed after 15 days from previous sternotomy, thus excluding reoperation for postoperative bleeding. We employed the EuroSCORE II as a cardiac surgery mortality predictor score with the only modification of replacing 'LVEF' by 'systemic ventricular ejection fraction'.
Other intervention refers to non-surgical cardiac procedures, such as electrophysiological or catheter interventions. Arrhythmia includes any type of sustained supraventricular or ventricular arrhythmia requiring therapy. Pulmonary hypertension was diagnosed according to recent guidelines. 13 For each subject, an estimated glomerular filtration rate (GFR) was calculated by the Cockroft-Gault formula. Patients were categorised into groups according to the National Kidney Foundation practice guidelines. Liver disease included any pre-existing form of liver disease plus any patient with a preoperative threefold increase in alanine aminotransferase test. Lung disease included any pre-existing form of lung disease (asthma, chronic obstructive lung disease, emphysema, etc), whereas there was a single entity for patients with diabetes mellitus, whether insulin-or non-insulin dependent.
Endpoints
The primary endpoint was early mortality (within 30 days from index cardiac surgery or during same admission of any duration). Additional analyses included (1) midterm to longer-term survival, (2) cumulative incidence of combined reoperation, other intervention and/or new-onset arrhythmia and (3) change in NYHA functional class for individuals over duration of follow-up. Independent predictors for early and total (early and midterm to longer-term) mortality were also sought.
Statistical analysis
Statistical analyses were performed using R software version 2.15.0. Continuous variables are presented as mean ± SD or median (IQR), whereas categorical variables are presented Congenital heart disease as number (percentage). Comparison between groups was performed using the Student's t test or the Mann-Whitney U test for continuous and χ 2 test or Fisher's test for categorical variables.
Logistic regression analysis was used to assess the association between variables and early mortality. Firth's correction was applied by performing Firth's penalised-likelihood logistic regression to take into account the small number of events. The logistf R package was used for this analysis. Univariate Cox proportional hazards analysis was used to assess the association between variables and total mortality. The log minus log survival (LML) plot was graphed to test whether the Cox proportional hazards assumption was met (if the LML plot resulted in parallel curves). The validity of the proportional hazards assumptions were tested by Schoenfeld residuals and could not be rejected at a p value of 0.05. Firth's correction was also applied to take into account the small number of events. The coxphf R package was used for this analysis. Significant parameters from the univariate analysis (p<0.05), except EuroSCORE II and Bethesda classification (width of the CI>7000), were subsequently included in a multiple regression analysis, and a selection procedure was applied to build a final regression model.
According to the variables retained in the multivariable model, different prognostic groups were defined based on the number of unfavourable prognostic factors. Kaplan-Meier curves and log-rank test were used to compare survival among these different groups.
Cumulative incidence of reoperation, of other intervention, of arrhythmia and of a composite endpoint including these three endpoints over time was estimated by taking into account the specific framework of competing risks (death being competitive with all these endpoints). The cmprsk R package was used for this analysis.
All tests were performed two-sided and for all analyses, a p value<0.05 was considered statistically significant.
RESULTS

Patients and surgery
One thousand and ninety adult patients with CHD underwent 1130 cardiac operations during the study period (age at surgery 35±14 years (range 15-82), 583 (53.5%) male). Forty-eight per cent of patients were symptomatic (24.8% of them with recent history of sustained arrhythmia, the remainder had primarily dyspnea and fatigue). Consequently, in 52% of patients in NYHA class I, cardiac surgery was not performed because of symptoms but for prognostic reasons. Only 8% of patients had a history of acquired heart disease. The majority of surgery (97.3%; figure 1) was via a sternotomy (redo sternotomy in half) using cardiopulmonary bypass (96.3%). The diagnostic mix is detailed in table 1 and online supplementary table 1 . Surgery was elective in 1030 (94.5%) cases (table 2) . Five hundred and eighty (53.2%) patients had two or more haemodynamic lesions requiring surgical attention. Median EuroSCORE II was 2.4 (range 0.5-55.7). Mean bypass time was 112±64.9 min, whereas mean cross clamp time 62±48.6 min. Among the 568 reoperations, 27 patients suffered an injury either during redo sternotomy or during dissection of the heart; none linked to early postoperative death. Median length of total hospital stay was 9 (range 0-163) days, whereas median postoperative stay 7 (range 0-162) days. The vast majority of patients (97.4%) were discharged directly to home.
During the study, the number of ACHD surgeries performed increased from a mean of 79.3 cases/year in the first 3 years to a mean of 130.6 cases/year in the last 3 years (increase of 64.7%). This was mainly due to an increase in the number of patients with moderate complexity requiring surgery. Furthermore, in the last quartile of the study period, 58% of patients were in NYHA class I at time of surgery, compared with 50% only, in the three first quartile of the study period (p<0.02).
Outcome
Early mortality was 1.77% (n=20 patients). Seventy-nine patients (7%) were reoperated within the first week (4.5% for bleeding, 1.3% drainage of pericardial effusion, 0.5% reoperation under bypass for residual haemodynamic lesions, 0.4% permanent epicardial pacemaker insertion, 0.2% for surgery on peripheral vessels and 0.1% sternal wound dehiscence repair). Thirty-nine (3.5%) patients received a permanent pacemaker. Twelve (1.1%) patients had surgical site infection (eight superficial and four deep), whereas four (0.4%) had endocarditis diagnosed during the first postoperative year. Twenty-six (2.3%) patients had postoperative pneumonia, whereas 33 (2.9%) had prolonged intubation requiring tracheostomy. Forty-six (4.1%) patients required postoperative renal replacement therapy (only one needed long-term haemofiltration). Thirteen patients (1.2%) had a neurological complication (five cerebrovascular accidents with residual neurological deficit, two transient ischemic attacks and six peripheral nerve injuries (three phrenic nerves, one ulnar nerve, one vocal cord and one brachial plexus)). Nine hundred and forty-two (83.4%) patients had no complications. Over a mean follow-up of 2.8 (±2.6) years, 26 (2.4%) of the remaining 1070 patients died (total mortality 46 of 1090 (4.2%)). Overall midterm to longer-term survival probability was 96% at 5% and 94% at 10 years. At the latest follow-up, 903 (86.5%) patients were in NYHA class I, 125 (12.0%) in class II 16 (1.5%) in class III and none in class IV (improvement from baseline: p<0.0001, figure 2).
Cumulative incidence of reoperation, other intervention, and new-onset arrhythmia independently was 18%, 25.0% and Data are presented as number (%) or mean ± SD. The Rastelli procedure is a left ventricular to aorta via VSD tunnelisation and RV to pulmonary trunk conduit contruction. The Glenn procedure is a bidirectional superior cavopulmonary anastomosis. ASD, atrial septal defect; AVSD, atrioventricular septal defect; AVV, atrioventricular valvar; CABG, coronary arterial bypass graft; LV, left ventricle; PA, pulmonary artery; PAPVC, partially anomalous pulmonary venous connection; RV, right ventricle; RVOT, right ventricle outflow tract; SV, TCPC, total cavopulmonary connection threw extracardiac conduit; VSD, ventricular septal defect.
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16%, respectively, at 10 years, whereas cumulative incidence of a combination of the above 19% at 5% and 43% at 10 years (figure 3).
Predictors of mortality
Variables independently associated with early mortality were NYHA class ≥ III, TAPSE<15 mm and female gender, and with total mortality NYHA class ≥ III, TAPSE<15 mm and non-elective surgery (Table 3 ). The number of previous sternotomies was not independently associated with early or total mortality. Relative survival curves after ACHD surgery, according to number of risk factors for total mortality are presented in figure 4 .
DISCUSSION
Contemporary cardiac surgery for adult patients with CHD performed at a single tertiary reference centre with a multidisciplinary approach is associated with a low early and midterm to longer-term mortality and improved functional class. Indications for surgery were either onset of symptoms or prognostic. Advanced symptoms, female gender, baseline right ventricular dysfunction and/or non-elective cardiac surgery were all associated with worse outcome. There are clear reasons underpinning the increase in numbers and case complexity of adult patients with CHD undergoing cardiac surgery. [14] [15] [16] [17] [18] First, more and more patients with CHD are surviving now into adulthood, including patients with complex disease. 19 Second, as the cohort of ACHD increases in age, a greater percentage comes to require operation or reoperation. 2 20 Third, there has been a recent trend towards operating on patients who are mildly symptomatic or asymptomatic to improve prognosis. For example, pulmonary valve replacement late after repair of tetralogy of Fallot is currently being performed on patients with severe pulmonary regurgitation and right ventricular dilatation irrespective of symptoms (before clinical decompensation ensues). 21 Indeed, only half of our patients were symptomatic mostly with exertional dyspnoea and fatigue and/or sustained arrhythmia. Fifty-two per cent of patients were in NYHA class I at baseline, thus prognostic benefit was the primary driver for surgery.
Our data of early mortality of 1.77% and probability of survival of 96% and 94% at 5 and 10 years compare favourable to previous reports (early mortality rates varied from 1.5% to 8%. [2] [3] [4] [5] [6] [7] [8] [9] ) Many of these reports relied on data supplied by national registries and/or were compiled from multiple centres; furthermore, enrolled patients underwent surgery over a much wider timeframe during which the results and optimal timing of surgery have improved. The outcomes reported in our study reflect concentration of expertise in a tertiary environment and a multidisciplinary approach, essential for ACHD care. Indeed, all patients reported in our study were discussed at great length in this setting, where a consensus was reached to proceed with cardiac surgery. During the study period, there has been further evolution with regards to indications and timing of surgery, for example, for pulmonary valve replacement, and a clear trend towards a more prognostic approach, bringing cardiac surgery forward before overt symptoms develop. Analysis of our data supports this proactive approach. Risk factors for early and late mortality were NYHA class ≥ III, TAPSE<15 mm-the latter an established marker of right ventricular dysfunction-and non-elective surgery, all of them suggesting that deferring cardiac surgery may be associated with a worse outcome. Female gender was also a risk factor for early mortality in our series. There were no differences in demographics or NYHA class between genders but female subjects had more complex disease compared with male counterparts. The mechanism by which gender may act as a risk factor merits further investigation. 22 Neither number of sternotomies, nor cardiac injury at the time of resternotomy were predictive of total or postoperative mortality on multivariate analysis in our series and in others. 23 24 Parallel increase of EuroSCORE with the number of sternotomies and increased mortality risk may reflect a longer history of ACHD disease and associated increase in comorbidity, including right ventricular dysfunction, NYHA class worsening-predictors of mortality-rather than resternotomy per se. Fastidious planning and preparation to deal with injury to the heart and great vessels on resternotomy can further alleviate this risk. Thus, any reluctance to reoperate should not be part of the decision-making process, since any delay on these grounds may dramatically worsen the prognosis.
In absence of routinely used dedicated mortality score, identification of risk factors are essential, informing the decision-making process. While EuroSCORE II is now routinely used in adult cardiac surgery for the broader spectrum of acquired disease, it was originally introduced to predict mortality in patients undergoing coronary artery bypass surgery. Our data confirm that Euro-SCORE II tends to overestimate operative mortality of ACHD surgery 5 ( figure 5 ). It may, therefore, introduce a bias towards non-intervention.
The Aristotle comprehensive complexity score 11 and the European Association for Cardio Thoracic Surgery -Society of Thoracic Surgeon (EACTS-STS) score seem to offer good prognostic value following ACHD surgery, 25 26 but these score are not addressing case mix adjustment for the specific field of adult congenital heart surgery. Indeed, operative mortality of adults is significantly lower than in the paediatric population and the recently described specific ACHD mortality score appears to be promising. 27 Our data point to a significant number of reoperations, other intervention and new-onset arrhythmia in the midterm to longerterm follow-up, reinforcing the need for continued lifelong follow-up. [28] [29] [30] Increasingly, the need for further intervention forms an integral part of a treatment strategy considered and discussed at the initial decision making including the prospect of percutaneous intervention years after cardiac surgery.
Clinical relevance
Risk stratification of individual patients informed largely by non-invasive tests, followed by multidisciplinary discussion Congenital heart disease on surgical or other intervention-before overt symptoms and clinical decompensation ensue-has to be the hallmark of the ACHD service. This approach, which has now developed into standard practice, was facilitated by the identification of new prognostic markers. Functional decline, impaired right ventricular function and female gender were predictive of early mortality, whereas, functional decline, right ventricular function again and non-elective surgery were predictive of total mortality well into midterm to longer-term follow-up. The identified predictors of early and total mortality from our study, as well as the point that the number of sternotomies was not independently associated with mortality, clearly support this proactive approach. While survival is a robust outcome measure used here, functional class and quality of life are equally important. Our data suggest that patients significantly improved postsurgery in their NYHA class by their latest follow-up compared with baseline.
Strengths of our study include the inclusive and consecutive nature of a large patient cohort and the prospective and unbiased method of data collection. In addition, combining a highly detailed dataset (that can be only achieved in a singlecentre study) and a large number of patients (usually available in administrative databases) gave us the unique opportunity to investigate fully risk factors for mortality. However, we acknowledge some limitations. First, we did not attempt to control the practices of individual surgeons (which may be an important confounder for operative results). However, our multidisciplinary approach to decision making provides consistency and uniformity to a large extent. Second, our observational approach did not allow a direct assessment and validation of the impact of the identified prognostic indicators, but this should be the subject of future studies. Nevertheless, important predictors of outcome have been identified. There is scope for extending our observational study incorporating non-invasive tools such as cardiac MRI, cardiopulmonary exercise testing and quality of life data and examining the impact of earlier cardiac surgery, advocated here, on all these predictors and on long-term outcome.
CONCLUSION
Contemporary cardiac surgery for ACHD performed at a single, tertiary reference centre with a multidisciplinary approach is associated with low mortality and improved functional status. Also, our findings emphasise the point that surgery should not be delayed because of reluctance to reoperate only.
Figure 4
Kaplan-Meier survival curves according to number of risk factors for total mortality. Relative survival after surgery in adult patient with CHD, according to number of risk factors for total mortality (nonelective surgery, NYHA≥3, TAPSE<15 mm). NYHA, New York Heart Association; TAPSE, tricuspid annulus plane systolic excursion.
Figure 5
Comparison between predicted by EuroSCORE II and observed mortality in first sternotomy group and redo sternotomy group.
Key messages
What is already known about this subject? Congenital heart disease (CHD) is a global disease that comes with global challenges: the numbers of adult patients have now outgrown those of children with CHD, there are ongoing cardiac and other healthcare needs for this patient population and there has been uncertainty on timing, nature and outcomes of further interventions.
What does this study add?
We are addressing risk stratification and contemporary outcome from state of the art cardiac surgery for adults with CHD (ACHD). Surgery for ACHD is associated with improved functional status and low operative mortality, 1.77%. The number of sternotomies was not independently associated with neither early nor total mortality.
How might this study impact on clinical practice?
In this context, good result of cardiac surgery beyond childhood will lead more adult patients with CHD, many lost to follow-up, to benefit from such an approach, in a timely manner. Also, our findings emphasise the point that surgery should not be delayed because of reluctance to reoperate only.
